IRIDEX Introduces Non-Invasive MicroPulse Therapy for Glaucoma

News

06
MOUNTAIN VIEW, Calif., February 6, 2024 – Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
25
Mountain View, CA –January 25, 2024 - Iridex Corporation, headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in Lon...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
12
MOUNTAIN VIEW, CA – January 11, 2023 – Iridex Corporation, a global leader in innovative laser-based medical systems for the treatment of eye diseases...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
29
Action Retains Full Patient Access to MicroPulse® Transscleral Laser TreatmentMOUNTAIN VIEW, Calif., December 28, 2023 – Iridex Corporation (Nasdaq: I...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
19
The new Iridex PASCAL combines industry-leading speed and precision pattern scanning, Endpoint Management Technology, Pattern Scanning Laser Trabeculo...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
26
Mountain View, CA — September 26, 2022 — Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the t...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
05
Mountain View, CA — April 5, 2022 — Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatm...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
13
MOUNTAIN VIEW, Calif., January 11, 2022 -- Iridex Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results fo...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
05
An international expert consensus panel will discuss best practices in dosing and patient selection using MicroPulse TLT on November 6, 2021Panel memb...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
11
MOUNTAIN VIEW, Calif., May 11, 2021 -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 3, 2021. F...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
22
MOUNTAIN VIEW, Calif., March 22, 2021 -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended Janu...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
12
Mountain View, CA — March 10, 2021 — Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treat...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
02
Transaction provides $19.5 million cash to Iridex, as two leaders join forces in glaucoma and retinal disease treatment Iridex to host a conference c...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
11
MOUNTAIN VIEW, Calif., January 11, 2021 -- IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results fo...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
22
• Guidelines provide recommendations on the diagnosis and management of glaucoma within the EU • Nine MicroPulse TLT studies presented at the annual E...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
25
To our valued customers and partners, As the COVID-19 pandemic continues, our thoughts go out to those who have been impacted. Our priority at IRID...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
11
Mountain View, Calif. September 12, 2019 -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for th...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
21
MOUNTAIN VIEW, Calif., May 21, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical pro...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
29
Mountain View, Calif. April 29, 2019 -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the tr...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
18
Mountain View, Calif., April 18, 2019— IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the first quar...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
01
Mountain View, Calif. April 1, 2019 -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the tre...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
05
MOUNTAIN VIEW, Calif., March 5, 2019 -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended Decem...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
26
MOUNTAIN VIEW, Calif., Feb. 26, 2019 -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth qu...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
12
MOUNTAIN VIEW, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has resolved its differences with Q...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
08
Mountain View, Calif., January 8, 2019 — IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary operational and financial results for the ...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
04
Mountain View, Calif., December 4, 2018— IRIDEX Corporation (Nasdaq: IRIX) today announced Chief Financial Officer Atabak Mokari will leave the Compan...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
25
Mountain View, Calif., October 25, 2018 — IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in upcoming investor conf...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
23
Glaucoma and Retina Specialists Will Discuss the Benefits of MicroPulse® TechnologyMOUNTAIN VIEW, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- IRIDEX Cor...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
15
MOUNTAIN VIEW, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Dr. Robert Grove to the ...

[Read the rest of this article...]

Actions: E-mail | Permalink |
18
World-Renowned Ophthalmologists to Highlight Benefits of MicroPulse® Technology in Treating Patients with Glaucoma and Retinal Diseases MOUNTAIN ...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
06
Mountain View, Calif., September 6, 2018— IRIDEX Corporation (Nasdaq: IRIX) today announced the introduction of its updated TruFocus LIO Premiere™ las...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
30
Recent Study Published by U.S. News and World Report Highlighting the “Best Hospitals for Ophthalmology” Includes 35 IRIDEX CustomersMountain View Cal...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
20
Mountain View Calif., July 20, 2018 — The award-winning series, Innovations with Ed Begley Jr., will feature IRIDEX Corporation (Nasdaq: IRIX) t...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
10
Important Commercial Milestone Demonstrates Growing Worldwide Awareness of MicroPulse Technology for Treatment of Glaucoma Mountain View Calif.,&nbs...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
25
MOUNTAIN VIEW, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the approval of its CYCLO G6™ Glaucoma...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
25
MOUNTAIN VIEW, Calif., June 25, 2018 -- IRIDEX Corporation (Nasdaq:IRIX), a leading provider of innovative laser systems in ophthalmology, today annou...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
17
Mountain View Calif., May 16, 2018 -- IRIDEX Corporation(Nasdaq: IRIX) today announced that its products will be featured in five poster sessions cove...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
02
Clinical data on 586 glaucoma patients provides valuable insights for all ophthalmologists. Mountain View Calif., May 02, 2018 -- IRIDEX Corporation(N...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
06
DMG Productions uncovers the latest advances in ophthalmology. Mountain View Calif., September 06, 2017— The award-winning series, Innovations ...

[Read the rest of this article...]

Actions: E-mail | Permalink |
06
Icare’s Tonometer for Monitoring Intra-Ocular Pressure Adds to Recurring Revenue StreamMountain View Calif., Sept. 8, 2015— IRIDEX Corporation (Nasdaq...

[Read the rest of this article...]

Actions: E-mail | Permalink |
31
New iClip™ Closure Device Focused on Glaucoma with Broadening Applications in Other Specialties of OphthalmologyMountain View, Calif., March 30, 2015 ...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
18
Initial Orders Include the Recently Patented MicroPulse® P3 Disposable ProbeMountain View, Calif., March 17, 2015 —IRIDEX Corporation (Nasdaq:IRIX) an...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
27
Laser Platform Supports Family of Consumable Probes and Appliances Including Recently Patented MicroPulse® P3 Disposable Mountain View, Calif., F...

[Read the rest of this article...]

Posted in: News, Events
Actions: E-mail | Permalink |
03
Actions: E-mail | Permalink |
30
Read full article
Posted in: News
Actions: E-mail | Permalink |
18
Read the full article
Posted in: News
Actions: E-mail | Permalink |
28
Click to read the full article
Posted in: News
Actions: E-mail | Permalink |
12
Click to read the full article
Posted in: News
Actions: E-mail | Permalink |
07
Click to see full interview.
Actions: E-mail | Permalink |
30
Click to see full interview.

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
10
Read more
Posted in: News
Actions: E-mail | Permalink |
16
To learn why, Register Today!
Posted in: News
Actions: E-mail | Permalink |
15
Click here to watch testimonial by Steven D. Vold, M.D.
Posted in: News
Actions: E-mail | Permalink |
15
IRIDEX’ patented MicroPulseTM laser technology enables Fovea-friendlyTM therapy for sight-threatening eye diseasesMountain View Calif., November 9, 20...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
06
Performed with the IQ 577™ Laser and EndoProbe® Instrumentation Mountain View, CA, June 6, 2012— IRIDEX Corporation (NASDAQ: IRIX) to...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
05
Treatmydme.com Provides New Information for Diabetic Macular Edema Patients  Mountain View, Calif., June 5, 2012– IRIDEX Corporation annou...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |
27
Tissue-Sparing, Repeatable MicroPulse Laser Trabeculoplasty (MLT) Extends Versatility of IRIDEX Green (IQ 532) Laser   Mountain View Calif., Apr...

[Read the rest of this article...]

Posted in: News
Actions: E-mail | Permalink |